Creating new vaccine materials to improve immune responses
Design and characterization of biomimetic nanobiomaterials to elicit CD1-restricted T cell responses during sub-unit vaccination
This study is working on new types of vaccines that mix proteins and fats to help your immune system fight infections better, especially by getting more immune cells involved, which could lead to stronger and longer-lasting protection.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-10444924 on NIH RePORTER |
What this research studies
This research focuses on developing innovative vaccine materials that can better stimulate the immune system by combining both protein and lipid components. By using biomimetic nanobiomaterials, the project aims to enhance the effectiveness of subunit vaccines, which typically only include protein antigens. The approach involves designing materials that can activate a broader range of T cells, including those that respond to lipids, which are often overlooked in current vaccine strategies. This could lead to more effective immunizations that provide lasting protection against infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who may benefit from improved vaccination strategies, particularly those with conditions requiring enhanced immune responses.
Not a fit: Patients who are not seeking vaccination or those with conditions that do not involve immune system enhancement may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines that provide better long-term immunity and protection against various diseases.
How similar studies have performed: Other research has shown promise in using similar biomimetic approaches to enhance vaccine efficacy, indicating potential for success in this area.
Where this research is happening
Chicago, UNITED STATES
- Northwestern University — Chicago, United States (Active)
Researchers
- Principal investigator: Scott, Evan Alexander — Northwestern University
- Study coordinator: Scott, Evan Alexander
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.